Title: Prevalence of constipation in adults with obesity class II and III and associated factors
Version: 4 Date: 08 Mar 2021
Reviewer's report:
Prevalence of constipation in adults with obesity class II and III and associated factors
Overall the study has important scientific merit and there is room for improvements on the
manuscript to increase the clarity. Congratulations on the write-up and research.
The followings are comments according to sections of the manuscript.
Abstract:
•       Well written, no further comment. PR or adjustedPR ? Which one are you referring to
in your manuscript ?
Methodology
•       Line 126: Terminology used; super obesity: Where is your reference from ?
Currently obesity class I, obesity class II and obesity class III which is according to WHO
standard classification.
• Line 127: DASS questionnaire should used to measure depression, anxiety level. These
questionnaires are validated questionnaires for screening mental health status.
• Line 138: Polypharmacy; type of medications is need to specified. It is possible if the person is
thin and on polypharmacy to be constipation or not necessarily be obese and on polypharmacy
to be constipated.
Discussion
•      Is there any research conducted for Latin America Region to support your research?
Most of your references are quoted from other research and not many from Latin America
Region.
• Is there any research done on obesity class 1 and constipation ? you might want to compare
between obese class 1 and your current research to add on more information in your discussion
section.
Overall, a good attempt to investigate the association between obesity and constipation. Good
luck and all the best for your manuscript publication. Congrats once again.
Title: Prevalence of constipation in adults with obesity class II and III and associated factors
Version: 4 Date: 08 Mar 2021
Reviewer's report:
Prevalence of constipation in adults with obesity class II and III and associated factors
Overall the study has important scientific merit and there is room for improvements on the
manuscript to increase the clarity. Congratulations on the write-up and research.
The followings are comments according to sections of the manuscript.
Abstract:
•       Well written, no further comment. PR or adjustedPR ? Which one are you referring to
in your manuscript ?
Methodology
•       Line 126: Terminology used; super obesity: Where is your reference from ?
Currently obesity class I, obesity class II and obesity class III which is according to WHO
standard classification.
• Line 127: DASS questionnaire should used to measure depression, anxiety level. These
questionnaires are validated questionnaires for screening mental health status.
• Line 138: Polypharmacy; type of medications is need to specified. It is possible if the person is
thin and on polypharmacy to be constipation or not necessarily be obese and on polypharmacy
to be constipated.
Discussion
•      Is there any research conducted for Latin America Region to support your research?
Most of your references are quoted from other research and not many from Latin America
Region.
• Is there any research done on obesity class 1 and constipation ? you might want to compare
between obese class 1 and your current research to add on more information in your discussion
section.
Overall, a good attempt to investigate the association between obesity and constipation. Good
luck and all the best for your manuscript publication. Congrats once again.
Please review this paper.
user
Title: Prevalence of constipation in adults with obesity class II and III and associated factors
Version: 4 Date: 08 Mar 2021
Reviewer's report:
Prevalence of constipation in adults with obesity class II and III and associated factors
Overall the study has important scientific merit and there is room for improvements on the
manuscript to increase the clarity. Congratulations on the write-up and research.
The followings are comments according to sections of the manuscript.
Abstract:
•       Well written, no further comment. PR or adjustedPR ? Which one are you referring to
in your manuscript ?
Methodology
•       Line 126: Terminology used; super obesity: Where is your reference from ?
Currently obesity class I, obesity class II and obesity class III which is according to WHO
standard classification.
• Line 127: DASS questionnaire should used to measure depression, anxiety level. These
questionnaires are validated questionnaires for screening mental health status.
• Line 138: Polypharmacy; type of medications is need to specified. It is possible if the person is
thin and on polypharmacy to be constipation or not necessarily be obese and on polypharmacy
to be constipated.
Discussion
•      Is there any research conducted for Latin America Region to support your research?
Most of your references are quoted from other research and not many from Latin America
Region.
• Is there any research done on obesity class 1 and constipation ? you might want to compare
between obese class 1 and your current research to add on more information in your discussion
section.
Overall, a good attempt to investigate the association between obesity and constipation. Good
luck and all the best for your manuscript publication. Congrats once again.
assistant